US Stock MarketDetailed Quotes
VTAK Catheter Precision
- 0.431
- +0.006+1.34%
Close Sep 27 16:00 ET
- 0.447
- +0.016+3.71%
Post 20:02 ET
1.21MMarket Cap-34P/E (TTM)
0.449High0.415Low189.47KVolume0.425Open0.426Pre Close80.71KTurnover6.94%Turnover RatioLossP/E (Static)2.80MShares8.40052wk High0.08P/B1.18MFloat Cap0.37552wk Low--Dividend TTM2.73MShs Float275000.000Historical High--Div YieldTTM7.92%Amplitude0.375Historical Low0.425Avg Price1Lot Size
Catheter Precision Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 64.99%-1.7M | 83.89%-1.94M | 8.64%-20.62M | 37.55%-1.89M | 63.15%-1.83M | 19.32%-4.85M | -40.66%-12.05M | 18.31%-22.57M | 47.03%-3.03M | 31.17%-4.97M |
| Net income from continuing operations | -167.77%-4.22M | 95.97%-2.68M | -162.69%-70.57M | 91.80%-669K | 59.54%-1.93M | 81.34%-1.58M | -1,108.37%-66.4M | -7.16%-26.87M | 1.54%-8.16M | -10.82%-4.76M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 101.71%44K | --0 | --0 |
| Depreciation and amortization | 229.56%526K | -63.85%522K | 392.87%2.08M | 1,968.00%517K | 602.70%520K | -398.53%-406K | 676.34%1.44M | -73.10%421K | -92.06%25K | -79.95%74K |
| Other non cash items | 129.32%1.5M | -83.24%86K | -344.92%-7.21M | ---1.88M | ---716K | ---5.13M | --513K | 184.74%2.94M | --0 | --0 |
| Change In working capital | 119.93%480K | 102.34%119K | -1,391.59%-7.07M | -97.21%143K | 182.91%291K | -211.64%-2.41M | -47.07%-5.09M | 252.79%547K | 155.96%5.13M | -533.33%-351K |
| -Change in receivables | 17.95%-32K | 811.11%64K | ---66K | -333.33%-91K | 329.41%73K | -533.33%-39K | -80.00%-9K | --0 | 58.82%-21K | -79.52%17K |
| -Change in inventory | --0 | -5.56%-19K | 157.14%8K | --20K | -111.63%-5K | -31.25%11K | 75.34%-18K | 92.89%-14K | --0 | 127.92%43K |
| -Change in prepaid assets | 80.88%123K | -85.62%88K | 361.49%876K | -107.54%-37K | 171.91%233K | 125.95%68K | 355.00%612K | -323.33%-335K | 248.23%491K | -689.09%-324K |
| -Change in payables and accrued expense | 115.91%389K | 99.75%-14K | -797.96%-7.89M | -94.62%252K | 31.25%-11K | -429.22%-2.45M | -84.63%-5.68M | 376.79%1.13M | 141.42%4.69M | -105.57%-16K |
| -Change in other current assets | ---- | --0 | --4K | ---- | ---- | ---- | --3K | --0 | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 34.27%-234K | 73.63%-24K | 21.11%-71K |
| -Change in other working capital | ---- | ---- | ---- | ---- | --1K | ---1K | 107.69%5K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 64.99%-1.7M | 83.89%-1.94M | 8.64%-20.62M | 37.55%-1.89M | 63.15%-1.83M | 19.32%-4.85M | -40.66%-12.05M | 18.31%-22.57M | 47.03%-3.03M | 31.17%-4.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -125.00%-45K | 0.00%-22K | -390.48%-61K | -185.71%-18K | -1K | -20K | -22K | -93.62%21K | 2,200.00%21K | 0 |
| Net PPE purchase and sale | -125.00%-45K | 40.54%-22K | -461.90%-76K | -185.71%-18K | ---1K | ---20K | ---37K | -93.62%21K | 2,200.00%21K | --0 |
| Net business purchase and sale | --0 | --0 | --15K | --0 | --0 | --0 | --15K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -125.00%-45K | 0.00%-22K | -390.48%-61K | -185.71%-18K | ---1K | ---20K | ---22K | -99.45%21K | 2,200.00%21K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 352.54%267K | -101.30%-110K | -64.10%8.39M | -102.06%-107K | 0 | 111.43%59K | -24.53%8.43M | 56.14%23.36M | 3,592.20%5.21M | 75.69%7.5M |
| Net issuance payments of debt | --576K | 56.00%-110K | ---357K | ---107K | --0 | --0 | ---250K | --0 | --0 | --0 |
| Net common stock issuance | --0 | --0 | -56.43%8.24M | --0 | --0 | --59K | -35.45%8.18M | 21.75%18.91M | 5,300.00%5.29M | -78.58%944K |
| Proceeds from stock option exercised by employees | --0 | --0 | -79.94%1.15M | --0 | --0 | --0 | 4,480.00%1.15M | 7,614.86%5.71M | --0 | --5.68M |
| Net other financing activities | ---- | ---- | 48.96%-640K | --0 | --0 | --0 | 57.87%-640K | -234.40%-1.25M | -1,620.00%-86K | 714.08%872K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 352.54%267K | -101.30%-110K | -64.10%8.39M | -102.06%-107K | --0 | 111.43%59K | -24.53%8.43M | 56.14%23.36M | 3,592.20%5.21M | 75.69%7.5M |
| Net cash flow | ||||||||||
| Beginning cash position | -87.80%1.49M | -77.52%3.57M | 5.41%15.86M | -59.15%5.58M | -33.41%7.41M | -30.78%12.22M | 5.41%15.86M | -37.07%15.05M | -33.76%13.66M | -44.97%11.13M |
| Current changes in cash | 69.32%-1.48M | 43.04%-2.07M | -1,610.32%-12.29M | -191.46%-2.01M | -172.40%-1.83M | 26.30%-4.81M | -239.66%-3.64M | 109.19%814K | 139.53%2.2M | 538.64%2.53M |
| End cash Position | -99.78%16K | -87.80%1.49M | -77.52%3.57M | -77.52%3.57M | -59.15%5.58M | -33.41%7.41M | -30.78%12.22M | 5.41%15.86M | 5.41%15.86M | -33.76%13.66M |
| Free cash flow | 64.21%-1.74M | 83.76%-1.96M | 8.37%-20.7M | 37.31%-1.91M | 63.13%-1.83M | 18.99%-4.87M | -41.09%-12.09M | 19.02%-22.59M | 47.11%-3.04M | 32.55%-4.97M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data